Chapter 9 Endnotes for Arthritis and Autoimmune Disease: The Infection Connection

  Reflections On Methodology

1)         Saul AW. “Taking the cure: Claus Washington Jungeblut, M.D.: Polio Pioneer; Ascorbate Advocate.” J Orthomolecular Med, 2006. Vol 21, No 2. Online at


3)         Linus Pauling: Lysine/Ascorbate-Related Amelioration of Angina (Arterial Sclerosis) [JOM 1991] Remarkable Case History and Linus Pauling: The [In-]Effectiveness of the National Cancer Institute  [1977, After $ Billions, Still no AA studies]

4)         Find a similar smug, mocking approach at

5)         Detailed overview at

6) is Dr. Marshall’s website.

7)         E.g., Google [iatrogenic polio] or [iatrogenic AIDS]


9)         More detail on this topic at


11)        E.g.,  (1999) and (2002)

12)        Archives can be found at

13) (2011)

14) (2011)

15) Based on 240 FDA reports.

16)        This is an independent, non-FDA reporting site showing interactions: (2011)

17)        Global Market Intelligence Overview Monograph 2009.

18)        At this writing,100 mg tetracycline costs about 50 cents per tablet.  Doxycycline is 37 cents each. Generic minocycline costs about $2.40  each. Prescription NSAIDs like Naproxen and Celebrex cost about 55 cents each but they merely suppress painful symptoms. An overview of Minocin sources and costs as of 2011 appears In Appendix II and at

19)        Clark (1997) p. 9.


21)        Unattributed article, National Network for Immunzation Information. “Aluminum Adjuvents in Vaccines.” (2008) Online at

22)        Excellent diet regimen at

23) (2009)

24)        Bird (1991) and also

25)        Mattman (2000)




29)        Mattman (2000)

30)        See for advice on topics such as Choosing a Health Plan, Becoming a More Effective Patient, Managing Your Health Plan, Surviving Your Health Plan, and Appealing a Health Plan's Decision.

31)        Gray, Dr. Sonja. “The Managed Care Insurance Game.” Internet article at

32)        87% of HMOs provide nutrition classes. See other HMO statistics at

33)        See

34)        Scammell (1998) pg. 192.

35)        Elmer-DeWitt, Philip. “Smart Bombs for Targeting Deadly Tumors [The Future of Drugs].” TIME, January 15, 2001 and follow-up letter to the editor by Dr. Christine M. Csatary, May 14, 2001.

36)        Personal communication with a family friend and resident of southern Texas. She met these medical professionals (fellow patients) while obtaining her own treatments in Mexico. She interviewed them informally in the clinic’s waiting room in 1999-2000.

37)        The author fired four rheumatologists who would not even consider a discussion of any alternative treatments other than TNF blockers and other accepted mainstream drugs. They were given a sheaf of research papers describing Dr. Brown’s protocol, which they refused to read.

38)        This is the flawed study:

39)        The full list is at

40)        RA patients should show their doctors Appendix II of this book, written by a medical doctor explaining the details of Dr. Brown’s antibiotic treatment. Another excellent overview is at For Sarcoidosis or multiple infections, patients should acquaint their doctors with the Marshall Protocol. See

41)        Smith CJ, et al. “Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.” Arthritis Research & Therapy 2011, 13:R168. This was a study involving 15,716 patients treated with antibiotics for RA between 1998 and 2009. The study’s conclusion: “Rheumatologists have not embraced minocycline or doxycycline as primary treatment options for RA and reserve their use primarily in patients with long-standing, refractory disease.” This reluctance is surprising, considering minimal side effects and generally acceptable tolerance for the antibiotics, and their measurable effectiveness. The duration of just 3-6 months was not enough to significantly decrease the colony of pathogens. Online at

42) (Last updated 2011)

43)        The author has considerable experience in the design and management of large, sophisticated, secure databases and can attest to the feasibility of access control.

44)        Pareto chart designed by Karl Poehlmann.



Return to End Notes Directory